MSD Receives European Approval Of Its Atypical Antipsychotic Medication SYCREST(R) For The Treatment Of Manic Episodes ...

MSD (MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A). announced today that the European Commission has approved the Marketing Authorization Application (MAA) for SYCREST® (asenapine) sublingual tablets for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. Today's decision was based on recommendations ...

Community Links

Reach your community and publicize non-profit, community, or club activities here and on the Internet, at www.langleyadvance.com which includes the link Submit an Event.

Genetic drug test a coup for Louisville's SureGene

For people with schizophrenia or other mental disorders, finding the most effective drug is often a matter of trial and error. A collaboration between a small Louisville company and Medco, a major pharmacy benefit manager, could lead to wide use of a genetic test to identify the best drug.

Report: Bremner called cop a 'Nazi' during DUI arrest

Prominent attorney Anne Bremner called a police officer a "Nazi," smelled "overwhelmingly" of alcohol during a DUI arrest and started banging her head against a patrol car partition, according to a police report.

Lack of Sleep Can Cause Depression, Weight Gain

A collection of studies published Wednesday in the journal Sleep tackled some important questions this month